Thomas A. Neville, PhD, Discusses PSA Growth Rate

Thomas A. Neville, PhD
Published: Tuesday, Jul 08, 2014

Thomas A. Neville, PhD, CEO of Soar Biodynamics in Incline Village, Nevada, discusses PSA growth rate.

If PSA is growing early on at a considerable rate but the absolute growth is not great, a patient needs to be monitored carefully. If a patient is screened annually at this stage, depending on PSA baseline, a physician may choose to screen every three or six months. Neville says if PSA is growing at a high rate but is not yet at a high level, prostate cancer can be caught early.

The approach at Soar Biodynamics is close monitoring, annual testing, and early baseline to diagnose and treat at low PSAs. To avoid overtreatment, a physician should consider being patient with slower-growing PSAs.

Thomas A. Neville, PhD, CEO of Soar Biodynamics in Incline Village, Nevada, discusses PSA growth rate.

If PSA is growing early on at a considerable rate but the absolute growth is not great, a patient needs to be monitored carefully. If a patient is screened annually at this stage, depending on PSA baseline, a physician may choose to screen every three or six months. Neville says if PSA is growing at a high rate but is not yet at a high level, prostate cancer can be caught early.

The approach at Soar Biodynamics is close monitoring, annual testing, and early baseline to diagnose and treat at low PSAs. To avoid overtreatment, a physician should consider being patient with slower-growing PSAs.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x